Back to Search
DOMINIC DIZON, M.D.
M.D.
Internal Medicine Physician
NPI: 1659384295IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
A62295(CA)
Education
UNIVERSITY OF CALIFORNIA, DAVIS SCHOOL OF MEDICINE
Class of 1995
Research & Publications (20)
Phase II trial of ixabepilone as second-line treatment in advanced endometrial cancer: gynecologic oncology group trial 129-P.
PMID 19451430·J Clin Oncol·2009
3-trial
For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?
PMID 18376226·Am J Clin Oncol·2008
8-other
Regional chemotherapy: a focus on hepatic artery infusion for colorectal cancer liver metastases.
PMID 18722916·Surg Oncol Clin N Am·2008
6-review
Does one person provide it all? Primary support and advanced care planning for women with cancer.
PMID 17416861·J Clin Oncol·2007
8-other
Ovarian cancer associated with testosterone supplementation in a female-to-male transsexual patient.
PMID 16804313·Gynecol Obstet Invest·2006
5-case
Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel. The Memorial Sloan-Kettering Cancer Center experience.
PMID 14675681·Gynecol Oncol·2003
4-observational
Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma: application toward a dynamic disease state model of ovarian cancer.
PMID 11870166·J Clin Oncol·2002
8-other
Intrahepatic arterial infusion of chemotherapy: clinical results.
PMID 11951210·Semin Oncol·2002
6-review
Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy.
PMID 11855873·Gynecol Oncol·2002
5-case
Is there a taxane-free interval that predicts response to taxanes as a later-line treatment of recurrent ovarian or primary peritoneal cancer?
PMID 19407557·Int J Gynecol Cancer·2009
8-other
Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2.
PMID 19359030·Gynecol Oncol·2009
8-other
Society of gynecologic oncologists position paper: breast cancer care.
PMID 18589209·Gynecol Oncol·2008
8-other
Impaired placental trophoblast lineage differentiation in Alkbh1(-/-) mice.
PMID 18163532·Dev Dyn·2008
4-observational
Oral thalidomide as palliative chemotherapy in women with advanced ovarian cancer.
PMID 17298255·J Palliat Med·2007
8-other
Sex, intimacy, and the gynecologic oncologists: survey results of the New England Association of Gynecologic Oncologists (NEAGO).
PMID 18032265·J Psychosoc Oncol·2007
8-other
Clinical characteristics of women presenting with skin-only recurrence of breast cancer.
PMID 17826063·Am J Surg·2007
8-other
A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors.
PMID 17364235·Invest New Drugs·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 7035 N MAPLE AVE STE 102B
FRESNO, CA 93720 - Phone
- (559) 299-2997
Quick Facts
- NPI
- 1659384295
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile